U.S. market Closed. Opens in 6 hours 57 minutes

BHAC | Crixus BH3 Acquisition Company Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for BHAC we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak.

Valuation (31%)

Company Industry
P/E Ratio (TTM) 14.32 -17.50
PEG Ratio (TTM) 0.00 -5.53
P/S Ratio (TTM) N/A 34.44
P/B Ratio (TTM) 2.77 5.76
P/FCF Ratio (TTM) -31.01 -146.44
Price to 5YR AVG Earnings Ratio 101.40 -34.29
Price to 5YR AVG FCF Ratio -70.12 -1.09

Profitability (20%)

Company Industry
ROA (TTM) 8.35% 287.39%
ROE (TTM) 6.76% -4,212.65%
Net Profit Margin (TTM) N/A -1,034.52%
ROIC 5YR AVG -2.34% -16.31%

Growth (33%)

4QTR AVG 3YR AVG 5YR AVG
EPS 187.39% -291.34% -146.07%
Revenue N/A 159.27% 75.56%
Net Income 225.14% -94.47% -63.79%
Cash Flow -104.40% -96.89% -70.72%

Health (42%)

Company Industry
Current Ratio (TTM) 0.08 4.93
Quick Ratio (TTM) 0.08 4.91
D/E Ratio (TTM) 0.13 1.27
Interest Coverage (TTM) -12.77 -11.12
Piotroski F-Score 4 3
Altman Z-Score 4.56 20.75
LTL to 5YR AVG FCF N/A -0.53
Shares Outstanding Growth 5YR AVG 235.53% 621.48%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙